MENU
+Compare
PCSA
Stock ticker: NASDAQ
AS OF
Aug 28, 04:58 PM (EDT)
Price
$0.21
Change
-$0.00 (-0.00%)
Capitalization
10.72M

PCSA Processa Pharmaceuticals Forecast, Technical & Fundamental Analysis

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products... Show more

PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PCSA with price predictions
Aug 27, 2025

PCSA in +2.57% Uptrend, growing for three consecutive days on August 26, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PCSA advanced for three days, in of 214 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where PCSA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PCSA just turned positive on August 26, 2025. Looking at past instances where PCSA's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PCSA as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PCSA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PCSA entered a downward trend on August 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.843) is normal, around the industry mean (19.660). P/E Ratio (0.000) is within average values for comparable stocks, (54.828). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.654). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (303.787).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PCSA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PCSA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7380 Coca Cola Drive
Phone
+1 443 776-3133
Employees
13
Web
https://www.processapharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CFG51.900.59
+1.15%
Citizens Financial Group
TEN21.790.20
+0.93%
Tsakos Energy Navigation Ltd.
CHRS1.140.01
+0.88%
Coherus Oncology Inc
GRBK69.650.03
+0.04%
Green Brick Partners
OST1.83-0.11
-5.67%
Ostin Technology Group Co Ltd

PCSA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PCSA has been loosely correlated with INO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PCSA jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCSA
1D Price
Change %
PCSA100%
-4.79%
INO - PCSA
38%
Loosely correlated
+20.59%
ONCO - PCSA
35%
Loosely correlated
-4.85%
MGX - PCSA
30%
Poorly correlated
-0.53%
EDIT - PCSA
28%
Poorly correlated
-2.20%
LVTX - PCSA
27%
Poorly correlated
+1.97%
More